Algawahmed H, Turcotte Robert, Farrokhyar F, Ghert M
Department of Surgery, McMaster University, Hamilton, ON, Canada L8V 5C2.
Sarcoma. 2010;2010. doi: 10.1155/2010/586090. Epub 2010 Jul 27.
Local control rates for Giant Cell Tumor of Bone (GCT) have been reported in a large number of retrospective series. However, there remains a lack of consensus with respect to the need for a surgical adjuvant when intralesional curettage is performed. We have systematically reviewed the literature and identified six studies in which two groups from the same patient cohort were treated with intralesional curettage and high-speed burring with or without a chemical or thermal adjuvant. Studies were evaluated for quality and pooled data was analyzed using the fixed effects model. Data from 387 patients did not indicate improved local control with the use of surgical adjuvants. Given the available data, we conclude that surgical adjuvants are not required when meticulous tumor removal is performed.
已有大量回顾性研究报道了骨巨细胞瘤(GCT)的局部控制率。然而,对于在进行病灶内刮除术时是否需要手术辅助治疗,目前仍未达成共识。我们系统回顾了文献,确定了六项研究,其中同一患者队列的两组分别接受了病灶内刮除术和高速磨钻治疗,且一组使用了化学或热辅助剂,另一组未使用。对研究进行质量评估,并使用固定效应模型对汇总数据进行分析。387例患者的数据并未表明使用手术辅助剂能改善局部控制情况。根据现有数据,我们得出结论,在进行细致的肿瘤切除时不需要手术辅助剂。